123 related articles for article (PubMed ID: 14659633)
1. Might telomerase enzyme be a possible target for trans-Pt(II) complexes?
Colangelo D; Ghiglia A; Viano I; Mahboobi H; Ghezzi A; Cassino C; Osella D
J Inorg Biochem; 2004 Jan; 98(1):61-7. PubMed ID: 14659633
[TBL] [Abstract][Full Text] [Related]
2. Cis-[Pt(Cl)2(pyridine)(5-SO3H-isoquinoline)] complex, a selective inhibitor of telomerase enzyme.
Colangelo D; Ghiglia AL; Viano I; Cavigiolio G; Osella D
Biometals; 2003 Dec; 16(4):553-60. PubMed ID: 12779240
[TBL] [Abstract][Full Text] [Related]
3. 5-Bromo-oxoisoaporphine platinum(II) complexes exhibit tumor cell cytotoxcicity via inhibition of telomerase activity and disruption of c-myc G-quadruplex DNA and mitochondrial functions.
Wei ZZ; Qin QP; Meng T; Deng CX; Liang H; Chen ZF
Eur J Med Chem; 2018 Feb; 145():360-369. PubMed ID: 29335202
[TBL] [Abstract][Full Text] [Related]
4. Uptake of antitumor platinum(II)-complexes by cancer cells, assayed by inductively coupled plasma mass spectrometry (ICP-MS).
Ghezzi A; Aceto M; Cassino C; Gabano E; Osella D
J Inorg Biochem; 2004 Jan; 98(1):73-8. PubMed ID: 14659635
[TBL] [Abstract][Full Text] [Related]
5. Platinum squares with high selectivity and affinity for human telomeric G-quadruplexes.
Zheng XH; Chen HY; Tong ML; Ji LN; Mao ZW
Chem Commun (Camb); 2012 Aug; 48(61):7607-9. PubMed ID: 22728887
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activities of a novel class of mono- and di-metallic Pt(II)(salicylaldiminato)(DMSO or Picolino)Cl complexes.
Rahman FU; Ali A; Guo R; Zhang YC; Wang H; Li ZT; Zhang DW
Dalton Trans; 2015 Feb; 44(5):2166-75. PubMed ID: 25510629
[TBL] [Abstract][Full Text] [Related]
7. Stabilization of human telomeric G-quadruplex and inhibition of telomerase activity by propeller-shaped trinuclear Pt(II) complexes.
Xu CX; Shen Y; Hu Q; Zheng YX; Cao Q; Qin PZ; Zhao Y; Ji LN; Mao ZW
Chem Asian J; 2014 Sep; 9(9):2519-26. PubMed ID: 24996049
[TBL] [Abstract][Full Text] [Related]
8. Two telomerase-targeting Pt(ii) complexes of jatrorrhizine and berberine derivatives induce apoptosis in human bladder tumor cells.
Qin QP; Wang ZF; Huang XL; Tan MX; Luo ZH; Wang SL; Zou BQ; Liang H
Dalton Trans; 2019 Oct; 48(40):15247-15254. PubMed ID: 31577283
[TBL] [Abstract][Full Text] [Related]
9. Stabilization of G-quadruplex DNA, inhibition of telomerase activity, and tumor cell apoptosis by organoplatinum(II) complexes with oxoisoaporphine.
Chen ZF; Qin QP; Qin JL; Liu YC; Huang KB; Li YL; Meng T; Zhang GH; Peng Y; Luo XJ; Liang H
J Med Chem; 2015 Mar; 58(5):2159-79. PubMed ID: 25650792
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of substituted 3-(2'-benzimidazolyl)coumarin platinum(II) complexes as new telomerase inhibitors.
Meng T; Qin QP; Wang ZR; Peng LT; Zou HH; Gan ZY; Tan MX; Wang K; Liang FP
J Inorg Biochem; 2018 Dec; 189():143-150. PubMed ID: 30265997
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, characterization, and biological evaluation of new tetrazole-based platinum(II) and palladium(II) chlorido complexes--potent cisplatin analogues and their trans isomers.
Serebryanskaya TV; Yung T; Bogdanov AA; Shchebet A; Johnsen SA; Lyakhov AS; Ivashkevich LS; Ibrahimava ZA; Garbuzenco TS; Kolesnikova TS; Melnova NI; Gaponik PN; Ivashkevich OA
J Inorg Biochem; 2013 Mar; 120():44-53. PubMed ID: 23305964
[TBL] [Abstract][Full Text] [Related]
12. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay.
Raymond E; Sun D; Izbicka E; Mangold G; Silvas E; Windle B; Sharma S; Soda H; Laurence R; Davidson K; Von Hoff DD
Br J Cancer; 1999 Jul; 80(9):1332-41. PubMed ID: 10424733
[TBL] [Abstract][Full Text] [Related]
13. Cellular pharmacology of cis and trans pairs of platinum complexes in cisplatin-sensitive and -resistant human ovarian carcinoma cells.
O'Neill CF; Hunakova L; Kelland LR
Chem Biol Interact; 1999 Nov; 123(1):11-29. PubMed ID: 10597899
[TBL] [Abstract][Full Text] [Related]
14. Novel tacrine platinum(II) complexes display high anticancer activity via inhibition of telomerase activity, dysfunction of mitochondria, and activation of the p53 signaling pathway.
Qin QP; Wang SL; Tan MX; Wang ZF; Luo DM; Zou BQ; Liu YC; Yao PF; Liang H
Eur J Med Chem; 2018 Oct; 158():106-122. PubMed ID: 30205260
[TBL] [Abstract][Full Text] [Related]
15. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
16. Activation of trans geometry in bifunctional mononuclear platinum complexes by a non-bulky methylamine ligand.
Frybortova M; Novakova O; Stepankova J; Novohradsky V; Gibson D; Kasparkova J; Brabec V
J Inorg Biochem; 2013 Sep; 126():46-54. PubMed ID: 23770803
[TBL] [Abstract][Full Text] [Related]
17. Telomerase inhibition and cancer: might platinum based drugs have a future as anti-telomerase pharmacological approach?
Colangelo D; Osella D
Curr Med Chem; 2005; 12(26):3091-102. PubMed ID: 16375703
[TBL] [Abstract][Full Text] [Related]
18. Preparation of 4-([2,2':6',2″-terpyridin]-4'-yl)-N,N-diethylaniline Ni(II) and Pt(II) complexes and exploration of their in vitro cytotoxic activities.
Zou HH; Wang L; Long ZX; Qin QP; Song ZK; Xie T; Zhang SH; Liu YC; Lin B; Chen ZF
Eur J Med Chem; 2016 Jan; 108():1-12. PubMed ID: 26619388
[TBL] [Abstract][Full Text] [Related]
19. A novel platinum compound inhibits telomerase activity in vitro and reduces telomere length in a human hepatoma cell line.
Furuta M; Nozawa K; Takemura M; Izuta S; Murate T; Tsuchiya M; Yoshida K; Taka N; Nimura Y; Yoshida S
Int J Cancer; 2003 May; 104(6):709-15. PubMed ID: 12640677
[TBL] [Abstract][Full Text] [Related]
20. High in vitro and in vivo antitumor activities of luminecent platinum(II) complexes with jatrorrhizine derivatives.
Qin QP; Zou BQ; Wang ZF; Huang XL; Zhang Y; Tan MX; Wang SL; Liang H
Eur J Med Chem; 2019 Dec; 183():111727. PubMed ID: 31563806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
